Subspecialization in Oncology Increasingly Utilized
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 11, 2025 -- Subspecialization in oncology is increasing, but varies widely across cancer types and regions, according to a study published online Aug. 12 in the Annals of Internal Medicine.
Rene Karadakic, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a retrospective cohort study using Medicare claims data from 2007 to 2021 to quantify trends in oncologist subspecialized cancer care in the United States. Subspecialization was identified if oncologists managed more than 80 percent of chemotherapy episodes within a single cancer category.
The researchers found that from 2008 to 2020, there was an increase in the proportion of episodes managed by subspecialists, from 9 to 18 percent, among 18,633 oncologists and 9.25 million chemotherapy episodes. Across cancer types and regions, there was wide variation in utilization, with the highest levels seen in large metropolitan areas. Over time, differences by income widened: In 2020, 27.6 and 8.8 percent of episodes were managed by subspecialists in the highest-income and the lowest-income counties, respectively, despite higher cancer mortality in the latter.
"If patients of subspecialists receive more guideline-recommended care or have better outcomes, a critical question that requires further investigation, then targeted policies may be needed to address differences in utilization of subspecialized care," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
THURSDAY, Aug. 14, 2025 -- Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.